ImmunityBio, Inc. Common Stock
S$9.224
SGD
Last updated on --.
24h volume8.97M
24h highest9.3659 SGD
24h lowest9.0131 SGD
24h Price movement-0.55%
IBRX recent prices
24 Hours
-0.55%-S$0.05132
30 days
-6.40%-S$0.62225
60 days
+0.21%+S$0.019245
90 days
-18.17%-S$2.021
Key data
Previous close9.2761 SGD
Market cap10.11B SGD
Volume8.97M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.0521 SGD
Net income (FY)-1.10B SGD
Revenue (FY)180.87M SGD
Last report dateMay 7, 2026
About ImmunityBio, Inc. Common Stock
HeadquartersSAN DIEGO
Employees (FY)691.00
Revenue per employee (FY)261.76K SGD
Net income per employee (FY)-1.59M SGD
Listed onNasdaq
IBRX conversion tables
 |  |
|---|---|
| 0.5 IBRX | 4.612 SGD |
| 1 IBRX | 9.224 SGD |
| 5 IBRX | 46.12 SGD |
| 10 IBRX | 92.24 SGD |
| |
|---|---|
| 0.5 SGD | 0.054202 IBRX |
| 1 SGD | 0.1084 IBRX |
| 5 SGD | 0.54202 IBRX |
| 10 SGD | 1.084 IBRX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
IBRX is trading at S$9.224, -0.55% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IBRX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IBRX is currently trading at S$9.224, -0.55% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IBRX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IBRX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IBRX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IBRX's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
ImmunityBio, Inc. Common Stock's market cap is currently 10.11B SGD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume8.97M
24h highest9.3659 SGD
24h lowest9.0131 SGD
24h Price movement-0.55%
Start trade with IBRX Perpetual
Sign up to trade